Biofilm-Associated Infections

Persistent and hard-to-treat infections are often linked to the ability of microorganisms to form structured communities known as biofilms. Biofilm-Associated Infections represent a major clinical challenge due to their resistance to antimicrobial treatments and immune system defenses. These infections commonly occur on medical devices, tissues, and chronic wounds, leading to prolonged illness and increased healthcare burden. This session at the Infectious Diseases Conference explores the mechanisms, clinical implications, and management strategies associated with biofilm-related infections.

Biofilms are complex aggregates of microorganisms embedded within a protective extracellular matrix that enhances their survival. This structure allows pathogens to adhere to surfaces, communicate through signaling systems, and resist antimicrobial agents. As a result, infections involving biofilms often require higher drug concentrations and longer treatment durations. In healthcare settings, biofilms are frequently associated with catheter-related infections, prosthetic implants, and ventilator-associated complications, making infection control particularly challenging.

A parallel term, Microbial Biofilm Infections, highlights the same phenomenon, emphasizing the role of microbial communities in persistent disease conditions. Advances in molecular biology and imaging technologies are improving the understanding of biofilm formation and behavior. Researchers are developing innovative strategies such as anti-biofilm agents, surface modifications, and targeted therapies to disrupt these structures and enhance treatment outcomes.

This session provides a comprehensive perspective on biofilm-associated infections, focusing on prevention, diagnosis, and therapeutic innovation. It aims to equip healthcare professionals with the knowledge required to address these complex infections effectively and improve patient care outcomes.